SHAREHOLDER ALERT: Brower Piven Encourages Investors Who

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Movado Group, Inc. to Contact Brower Piven Before the Lead Plaintiff Deadline in Class Action Lawsuit -- MOV

STEVENSON, Md., Feb. 27, 2015 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Movado Group, Inc. ("Movado" or the "Company") (NYSE: MOV ) securities during the period between March 25, 2014 and November 13, 2014, inclusive (the "Class Period"). Investors who wish to become proactively involved in the litigation have until April 6, 2015 to seek appointment as lead plaintiff.

If you have suffered a loss from investment in Movado securities purchased on or after March 25, 2014 and held through the revelation of negative information during and/or at the end of the Class Period, as described below, and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html . You may also request more information by contacting Brower Piven either by email at hoffman@browerpiven.com or by telephone at (410) 415-6616. No class has yet been certified in the above action. Members of the Class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff.

If you wish to choose counsel to represent you and the Class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement and how much of a settlement to accept for the Class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Company securities during the Class Period. Brower Piven also encourages anyone with information regarding the Company's conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.

The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants' failure to disclose that MGI's watch brands were suffering from poor performance in fiscal 2015. Defendants also made materially false and/or misleading statements about the purportedly attractive business prospects and strong growth expected for the Company's flagship Movado brand, as well as its portfolio of licenses brands. Additionally, the Company misled investors regarding its initiative to boost the Movado brand by cannibalizing the ESQ brand's shelf space at various retailers. On November 14, 2014, Movado announced disappointing third quarter financial results, stated that it would be lowering its fiscal year 2015 guidance, and revealed that certain brands, including Movado, Lacoste, and Scuderia Ferrari had not performed as well as expected.

According to the complaint, following the Company's November 14, 2014 announcement, the value of Movado shares declined significantly.

Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.

Charles J. Piven Brower Piven, A Professional Corporation 1925 Old Valley Road Stevenson, Maryland 21153 Telephone: 410-415-6616

Scroll down for more posts ▼

Top 10 Most Recent News Articles

JiMMYBAR! Unveils World's First Creatine Trail Mix

Updated Category News Views 3

The New Face of Snacking: Creatine Trail Mix I'll tell you right off the bat, JiMMYBAR! seems to be cornering the snack world with an odd—but interesting—twist. They've just launched the world's first Creatine + Protein Trail Mix, blending muscle-building nutrients with the classic crunch of trail mix. Sounds quirky, and it’s exclusive to their site, JiMMYBARs.com....

Continue Reading
Jaguar Promise Tackles College Cost for Texas Students

Updated Category News Views 3

Transforming Aspirations into Achievements In the heart of San Antonio, something’s cooking at A&M University-San Antonio, and it's not just the classic breakfast tacos. They've hit a record-breaking enrollment of 7,697 students this Fall, with 1,322 being fresh-faced first-timers. And while that might grab your attention, the real headliner is their Jaguar Promise...

Continue Reading
xFusion Tackles Cooling and Power at OCP 2026

Updated Category News Views 4

Bracing for an AI Revolution Ah, the world of AI — it's like the wild west out there, with data centers struggling to keep up as workloads skyrocket. Enter xFusion, a veteran in the computing infrastructure game, rolling out some seriously impressive tech at the 2026 Open Compute Project (OCP) Global Summit. The company's latest offering showcases how they're tackling...

Continue Reading
Puori Protein Transparency Pays Off Amid Lead Scare

Updated Category News Views 5

Puori's Moment of Reckoning The world of nutritional supplements is no stranger to controversy, but when Puori found itself caught in the storm of the Consumer Reports investigation last year, it chose a road less traveled: transparency and accountability. Faced with alarming news that over two-thirds of tested protein powders exceeded California's Proposition 65 lead...

Continue Reading
New Data on SKYRIZI Offers Hope for Crohn's Patients

Updated Category News Views 34

Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...

Continue Reading
Honeywell Aerospace Faces Legal Turbulence in Fraud Case

Updated Category News Views 17

If you've got your chips on Honeywell Aerospace, Inc. (HONA), buckle up because things are getting choppy. Investors who took a bath on their shares now have the chance to put on their legal gloves and join a securities fraud class action lawsuit against the company. Legal Storm Over Misleading Statements Here's the rub: Between June 29 and September 1, 2026, the folks at...

Continue Reading
AI-Powered Travel Transformation in Norway Revealed

Updated Category News Views 6

AI-Driven Travel Meets Norway's Authentic Charm Well, folks, once again we're staring down the barrel of technology going full throttle in the travel game. Mindtrip, the savvy AI-powered travel platform, just inked a deal with the Norwegian Travel Cluster. It's their first tango in Europe, and they're not dipping their toes—they're diving headfirst into the icy fjords....

Continue Reading
Tessa AI: Revolutionizing Biomedical Research with AI

Updated Category News Views 1

Shaking Up Research Evaluation When Siensmetrica decided it was high time for a name change, morphing into Tessa AI wasn't just a cosmetic shift. It was a nod to what stakeholders were already calling it and laid the ground for a broader mission statement. They're not sitting on their hands; they're crafting tools that tackle the scientific life cycle from start to...

Continue Reading
Laars Welcomes Women in Manufacturing to Facility Tour

Updated Category News Views 15

Opening Doors and Minds in Manufacturing On October 15, Laars Heating Systems throws wide open its Rochester, N.H., facility to a group that's rewriting the rulebook: women in manufacturing. It's not just another day in the life of assembly lines and engineering desks, folks. This is about giving a platform to those often sidelined in the field of boilers and water...

Continue Reading
WIN Expands Leadership Amidst Rapid Growth Surge

Updated Category News Views 6

Why WIN's Leadership Shake-Up Matters Change is afoot at the fertility and family support powerhouse WIN, and there's no mistaking the bold handwriting on the wall. As they swell towards supporting one million families, WIN's revamping their leadership table with three key players aimed at pushing the envelope further than before. They've got Claudio Stefan, Stacey...

Continue Reading

Top 5 Most Recently Viewed Articles

Explore the New 1 Hotel in Denmark's Capital City

Updated Category News Views 260

Explore the New 1 Hotel in Denmark's Capital City 1 Hotels, known for its commitment to sustainability and luxury, is gearing up to welcome guests to its newest property, 1 Hotel Copenhagen. This highly anticipated urban retreat has opened reservations, inviting travelers to experience a unique blend of nature and urban life. The hotel is set to open soon, transforming...

Continue Reading
Oracle Leverages Google and OpenAI for Cloud Growth

Updated Category Stocks Views 637

Though revenue projections were not met, Oracle's recent financial results show growth in cloud services. Oracle's stock has increased and it is now well-positioned in the cutthroat cloud infrastructure industry thanks to strategic cloud agreements with Google and OpenAI. Using partnerships and database management experience, the company intends to grow its worldwide...

Continue Reading
Heather L. Walter Recognized as Pinnacle Lifetime Member 2026

Updated Category News Views 129

Celebrating Heather L. Walter’s Achievements In a significant acknowledgment, Dr. Heather L. Walter, Ed.D., has been recognized as a 2026 Pinnacle Lifetime Member for her invaluable contributions in the field of special education and educator wellbeing. This honor reflects her unwavering commitment to advancing the standards of education and supporting educators in...

Continue Reading
Amgen's New Drug Trial Results Fall Short for Cancer Patients

Updated Category News Views 253

Amgen's Recent Trial Outcomes for Gastric Cancer Drug Amgen Inc. and its collaborator Zai Lab have revealed the final results of their Phase 3 trial evaluating bemarituzumab when used with the chemotherapy regimen mFOLFOX6 for gastric cancer. This much-anticipated data from the FORTITUDE-101 trial has now completed. Initial Promising Results In the preliminary analysis,...

Continue Reading
Atlantica Sustainable Infrastructure's Major Acquisition Update

Updated Category News Views 226

Atlantica Sustainable Infrastructure's Acquisition Timeline Atlantica Sustainable Infrastructure plc (NASDAQ: AY) is on the verge of a pivotal moment with its acquisition by Energy Capital Partners and co-investors. The expected completion, projected for December 12, 2024, signals a significant evolution for Atlantica as it transitions into a new chapter. The details of...

Continue Reading